Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MeiraGTx Holdings PLC (MGTX) vs Replimune Group, Inc. (REPL)

MeiraGTx Holdings PLC and Replimune Group, Inc. are both Biotechnology companies. Replimune Group, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Replimune Group, Inc. has negative trailing earnings, so its P/E is not meaningful; MeiraGTx Holdings PLC trades at 14.4×. MeiraGTx Holdings PLC has the higher net margin (19.9% vs 0.00%) and the higher return on invested capital (66.6% vs −1,154.7%). Across the 14 metrics below, MeiraGTx Holdings PLC leads on 13 and Replimune Group, Inc. on 1.

Valuation

Metric MGTX REPL Biotechnology median
P/E 14.36 n/m 7.88
P/S 2.51 n/m 11.47
P/B 4.62 11.37 2.52
Price to free cash flow 98.53 n/m 21.16
EV/EBITDA 4.83 n/m 0.74
EV/Sales 2.40 n/m 10.73
Earnings yield 6.97% (25.40%) (28.84%)
Free cash flow yield 1.01% (23.36%) (23.03%)

Profitability

Metric MGTX REPL Biotechnology median
Gross margin 97.95% 0.00% 65.16%
Operating margin 46.30% 0.00% 0.00%
Net margin 19.87% 0.00% 0.00%
Free cash flow margin 2.55% 0.00% 0.00%
Return on equity 72.22% (134.29%) (57.72%)
Return on assets 26.54% (82.28%) (49.22%)
Return on invested capital 66.60% (1,154.69%) 0.00%

Growth

Metric MGTX REPL Biotechnology median
Revenue growth (TTM) 948.35% — 5.64%
EPS growth (last fiscal year) 33.02% (10.10%) —
Revenue growth, 5-year CAGR 39.22% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MGTX REPL Biotechnology median
Debt to equity 0.46 1.00 0.00
Current ratio 3.76 5.23 4.73
Net debt to EBITDA 0.18 0.51 0.96

Dividend

Metric MGTX REPL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MGTX REPL Biotechnology median
Market cap 1.06b 1.20b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack